Venous thromboembolic risk and its prevention in hospitalized medical patientsHAAS, Sylvia K.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 6, pp 577-583, issn 0094-6176, 7 p.Article

Venous thromboembolism in medical patients: The scope of the problemHAAS, Sylvia.Seminars in thrombosis and hemostasis. 2003, Vol 29, pp 17-21, issn 0094-6176, 5 p., SUP1Conference Paper

Oral direct thrombin inhibition: an effective and novel approach for venous thromboembolismHAAS, Sylvia.Drugs (Basel). 2004, Vol 64, pp 7-16, issn 0012-6667, 10 p., SUP1Article

Strengths and Limitations of Standards of Care to Guide the Orthopedic Surgeon in VTE PreventionFRIEDMAN, Richard J; HAAS, Sylvia.Orthopedics (Thorofare). 2011, Vol 34, Num 2, pp 121-128, issn 0147-7447, 8 p.Article

Hemostasis and Thrombosis in Gynecology and Obstetrics, Aging, Malignancy, and Medical PatientsSUZUKI, Shigenori; HAAS, Sylvia.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 6, issn 0094-6176, 94 p.Serial Issue

Discussion and debate on thromboembolism: Based on the proceedings of the 10th International Symposium on Thromboembolism, June 2003, London, United KingdomKAKKAR, Ajay K; HAAS, Sylvia; LEVINE, Mark et al.Seminars in thrombosis and hemostasis. 2003, Vol 29, issn 0094-6176, 39 p., SUP1Conference Proceedings

The emerging role of low molecular weight heparin in venous thromboembolism. SymposiumHAAS, Sylvia; LOWE, Gordon D. O.Drugs (Basel). 1996, Vol 52, issn 0012-6667, 70 p., SUP7Conference Proceedings

Novel oral anticoagulants - key messages for the angiologistHAAS, Sylvia; SPANNAGL, Michael; SCHELLONG, Sebastian M et al.VASA (Bern). 2012, Vol 41, Num 3, pp 177-191, issn 0301-1526, 15 p.Article

Thromboembolism: New Insights and Future ProspectsHAAS, Sylvia; MARDER, Victor J; SAMAMA, Meyer-Michel et al.Haemostasis. 2000, Vol 30, issn 0301-0147, 184 p., SUP2Conference Proceedings

Applying risk assessment models in general surgery : overview of our clinical experienceAGENO, W.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S71-S78, issn 0957-5235, SUP2Conference Paper

Limitations of established antithrombotic strategiesHAAS, S.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S11-S18, issn 0957-5235, SUP2Conference Paper

Thromboprophylaxis and thrombosis in medical, surgical, trauma, and obstetric/gynecologic patientsBICK, Rodger L; HAAS, Sylvia.Hematology/oncology clinics of North America. 2003, Vol 17, Num 1, issn 0889-8588, viii, 217-258 [43 p.]Article

From foundations to the future: building a new era in DVT managementHAAS, Sylvia; TURPIE, Alexander G. G.Blood coagulation & fibrinolysis. 1999, Vol 10, issn 0957-5235, 133 p., SUP2Conference Proceedings

Future prospects of prophylaxis for deep vein thrombosisPINI, M.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S19-S27, issn 0957-5235, SUP2Conference Paper

Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patientsHAAS, S.Seminars in thrombosis and hemostasis. 1999, Vol 25, pp 101-105, issn 0094-6176, SUP3Conference Paper

Low molecular weight heparins in the management of unstable anginal non-Q-wave myocardial infarctionCOHEN, M.Seminars in thrombosis and hemostasis. 1999, Vol 25, pp 113-121, issn 0094-6176, SUP3Conference Paper

The postdischarge risk of venous thromboemnbolism after hip replacement : The role of prolonged prophylaxisBERGQVIST, D.Drugs (Basel). 1996, Vol 52, pp 55-59, issn 0012-6667, SUP7Conference Paper

Applying risk assessment models in non-surgical patients : effective risk stratificationELDOR, A.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S91-S97, issn 0957-5235, SUP2Conference Paper

Differentiation of low molecular weight heparins in acute coronary syndromes : An interventionalist's perspectiveGULBA, D.Seminars in thrombosis and hemostasis. 1999, Vol 25, pp 123-127, issn 0094-6176, SUP3Conference Paper

Thromboembolism: New Achievements and Challenges: Proceedings of the 6th International Symposium on Thromboembolic Diseases, Lisbon, June 4-5, 1999HAAS, Sylvia; LEVINE, Mark; SAMAMA, Meyer-Michel et al.Haemostasis. 1999, Vol 29, issn 0301-0147, 136 p., SUP1Conference Proceedings

Differentiation of Low Molecular Weight Heparins: Applied and Clinical ConsiderationsFAREED, Jawed; HAAS, Sylvia; SASAHARA, Arthur et al.Seminars in thrombosis and hemostasis. 1999, Vol 25, issn 0094-6176, 150 p., SUP3Conference Proceedings

Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients : The MC-4 cancer substudyKAKKAR, Ajay K; HAAS, Sylvia; WOLF, Helmut et al.Thrombosis and haemostasis. 2005, Vol 94, Num 4, pp 867-871, issn 0340-6245, 5 p.Article

Low-molecular-weight heparins: Beyond thrombosis in the management of the cancer patientKAKKAR, Ajay K.Seminars in thrombosis and hemostasis. 2003, Vol 29, pp 13-15, issn 0094-6176, 3 p., SUP1Conference Paper

Factor Xa is a superior target to factor IIa for antithrombotic therapiesBÜLLER, Harry R.Seminars in thrombosis and hemostasis. 2003, Vol 29, issn 0094-6176, p. 37, SUP1Conference Paper

Applying risk assessment models in orthopaedic surgery : overview of our clinical experienceGALLUS, A. S.Blood coagulation & fibrinolysis. 1999, Vol 10, pp S53-S61, issn 0957-5235, SUP2Conference Paper